167 related articles for article (PubMed ID: 16542460)
1. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.
Endimiani A; Luzzaro F; Pini B; Amicosante G; Rossolini GM; Toniolo AQ
BMC Infect Dis; 2006 Mar; 6():52. PubMed ID: 16542460
[TBL] [Abstract][Full Text] [Related]
2. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
Endimiani A; Luzzaro F; Brigante G; Perilli M; Lombardi G; Amicosante G; Rossolini GM; Toniolo A
Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
[TBL] [Abstract][Full Text] [Related]
3. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
4. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
[TBL] [Abstract][Full Text] [Related]
5. Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.
Willmann M; Kuebart I; Marschal M; Schröppel K; Vogel W; Flesch I; Markert U; Autenrieth IB; Hölzl F; Peter S
BMC Infect Dis; 2013 Nov; 13():515. PubMed ID: 24176052
[TBL] [Abstract][Full Text] [Related]
6. Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): Molecular typing of superbug strains in bloodstream infections (BSI).
Tahmasebi H; Dehbashi S; Arabestani MR
Infect Genet Evol; 2020 Nov; 85():104518. PubMed ID: 32891877
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates of Pseudomonas aeruginosa].
Zarakolu P; Metan G; Gürkan Aydin N; Altun B; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Jul; 41(3):363-7. PubMed ID: 17933246
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
9. Spread of extended-spectrum β-lactamase genes of blaOXA-10, blaPER-1 and blaCTX-M in Pseudomonas aeruginosa strains isolated from burn patients.
Farshadzadeh Z; Khosravi AD; Alavi SM; Parhizgari N; Hoveizavi H
Burns; 2014 Dec; 40(8):1575-80. PubMed ID: 24767142
[TBL] [Abstract][Full Text] [Related]
10. Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.
Polotto M; Casella T; de Lucca Oliveira MG; Rúbio FG; Nogueira ML; de Almeida MT; Nogueira MC
BMC Infect Dis; 2012 Aug; 12():176. PubMed ID: 22863113
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals.
Glupczynski Y; Bogaerts P; Deplano A; Berhin C; Huang TD; Van Eldere J; Rodriguez-Villalobos H
J Antimicrob Chemother; 2010 May; 65(5):866-71. PubMed ID: 20200037
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates.
Lin SP; Liu MF; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2012 Jun; 45(3):200-7. PubMed ID: 22209695
[TBL] [Abstract][Full Text] [Related]
16. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran.
Jabalameli F; Mirsalehian A; Sotoudeh N; Jabalameli L; Aligholi M; Khoramian B; Taherikalani M; Emaneini M
Burns; 2011 Nov; 37(7):1202-7. PubMed ID: 21703769
[TBL] [Abstract][Full Text] [Related]
17. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
Li JQ; Tang CQ; Wang H; Ji SZ; Lü KY; Xiao SC; Deng AM; Huang Y; Xia ZF
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1903-6. PubMed ID: 27373357
[TBL] [Abstract][Full Text] [Related]
18. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients.
Mirsalehian A; Feizabadi M; Nakhjavani FA; Jabalameli F; Goli H; Kalantari N
Burns; 2010 Feb; 36(1):70-4. PubMed ID: 19524369
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
20. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Chopra T; Marchaim D; Veltman J; Johnson P; Zhao JJ; Tansek R; Hatahet D; Chaudhry K; Pogue JM; Rahbar H; Chen TY; Truong T; Rodriguez V; Ellsworth J; Bernabela L; Bhargava A; Yousuf A; Alangaden G; Kaye KS
Antimicrob Agents Chemother; 2012 Jul; 56(7):3936-42. PubMed ID: 22547616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
